Patents by Inventor Sampo Lahtinen

Sampo Lahtinen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIFIDOBACTERIA FOR REDUCING FOOD, ENERGY AND/OR FAT INTAKE
    Publication number: 20240115630
    Abstract: This invention relates to the use of a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis strain 420 (B420) for use in reducing food, energy and/or fat intake.
    Type: Application
    Filed: May 15, 2023
    Publication date: April 11, 2024
    Inventors: Lotta Stenman, Sampo Lahtinen
  • LACTOBACILLI FOR TREATING CARDIAC DYSFUNCTION
    Publication number: 20240041953
    Abstract: The use of a bacterium of the species Lactobacillus salivarius in the manufacture of a food product, dietary supplement or medicament for treating cardiac dysfunction, particularly myocardial infarction, congestive heart failure, dilated cardiomyopathy or inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis) is disclosed.
    Type: Application
    Filed: March 31, 2023
    Publication date: February 8, 2024
    Inventors: Lotta Stenman, Sampo Lahtinen, John Konhilas
  • BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS
    Publication number: 20230248786
    Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.
    Type: Application
    Filed: September 12, 2022
    Publication date: August 10, 2023
    Inventors: Remy Burcelin, DIDIER CARCANO, SAMPO LAHTINEN
  • BACTERIA
    Publication number: 20220354908
    Abstract: The present invention relates to bacteria and metabolites thereof that are capable of binding to vaginal cells and producing hydrogen peroxide, their use in probiotic compositions and food products and methods for their selection. The invention also relates to the use of said bacteria, metabolites and probiotic compositions for the prevention and/or treatment of urogenital disorders.
    Type: Application
    Filed: January 19, 2022
    Publication date: November 10, 2022
    Inventors: Heli Putaala, Sofia Forssten, Sampo Lahtinen, Arthur Ouwehand, Jaana Mättö, Harri Mäkivuokko, Inger Mattsby-Baltzer, Björn Andersch
  • BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS
    Publication number: 20220339215
    Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction and congestive heart failure.
    Type: Application
    Filed: February 7, 2022
    Publication date: October 27, 2022
    Inventors: REMY BURCELIN, DIDIER CARCANO, SAMPO LAHTINEN, LOTTA STENMAN, JOHN KONHILAS
  • METHOD OF TREATMENT
    Publication number: 20210379126
    Abstract: The present invention relates to a method of treating or prophlaxis of a respiratory tract illness in a subject comprising administering to said subject a composition comprising Bifidobacterium lactis BL04 and/or fermentation product of Bifidobacterium lactis BL04 and/or a cell lysate of Bifidobacterium lactis BL04.
    Type: Application
    Filed: August 23, 2021
    Publication date: December 9, 2021
    Inventors: David Pyne, NICOLAS WEST, ALLAN CRIPPS, SAMPO LAHTINEN
  • METHOD FOR DETECTING SILICA
    Publication number: 20210381978
    Abstract: The present invention relates to utilization of lanthanide time resolved fluorescence for determining silica concentration. In the method sample comprising silica is admixed with a reagent comprising a lanthanide (III) ion and optionally a chelating agent, silica in the sample is allowed to interact with the reagent comprising the lanthanide (III) ion, followed by exciting the sample and detecting a signal deriving from the lanthanide (III) ion, and determining the concentration of the silica in the sample by using the detected signal.
    Type: Application
    Filed: September 27, 2019
    Publication date: December 9, 2021
    Inventors: Salla PUUPPONEN, Sampo LAHTINEN
  • LACTOBACILLI FOR TREATING CARDIAC DYSFUNCTION
    Publication number: 20210346439
    Abstract: The use of a bacterium of the species Lactobacillus salivarius in the manufacture of a food product, dietary supplement or medicament for treating cardiac dysfunction, particularly myocardial infarction, congestive heart failure, dilated cardiomyopathy or inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis) is disclosed.
    Type: Application
    Filed: June 30, 2020
    Publication date: November 11, 2021
    Inventors: Lotta Stenman, Sampo Lahtinen, John Konhilas
  • BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS
    Publication number: 20210322491
    Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.
    Type: Application
    Filed: February 19, 2021
    Publication date: October 21, 2021
    Inventors: Remy Burcelin, Didier Carcano, Sampo Lahtinen
  • BIFIDOBACTERIA FOR REDUCING FOOD, ENERGY AND/OR FAT INTAKE
    Publication number: 20210244778
    Abstract: This invention relates to the use of a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis strain 420 (B420) for use in reducing food, energy and/or fat intake.
    Type: Application
    Filed: October 22, 2020
    Publication date: August 12, 2021
    Inventors: Lotta Stenman, Sampo Lahtinen
  • BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS
    Publication number: 20200316144
    Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.
    Type: Application
    Filed: February 24, 2020
    Publication date: October 8, 2020
    Inventors: Remy Burcelin, DIDIER CARCANO, SAMPO LAHTINEN
  • BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS
    Publication number: 20200306322
    Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction and congestive heart failure.
    Type: Application
    Filed: January 30, 2020
    Publication date: October 1, 2020
    Inventors: Remy Burcelin, Didier CARCANO, Sampo LAHTINEN, Lotta STENMAN, John KONHILAS
  • Immunomodulatory composition comprising bifidobacteria
    Patent number: 10668117
    Abstract: The present invention relates to composition derivable from a bifidobacteria, methods and uses thereof, for use in modulating the immune system in a subject by affecting viral action and/or viral effects in said subject. Furthermore, said composition may also be used in reducing the risk of development and exacerbation of chronic respiratory diseases such as asthma and COPD in a subject; preferably by modulating the immune system in the subject by affecting viral action and/or viral effects in said subject.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: June 2, 2020
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Markus Lehtinen, Sampo Lahtinen, Ronald B. Turner
  • BACTERIA
    Publication number: 20200085888
    Abstract: The present invention relates to bacteria and metabolites thereof that are capable of binding to A, B and/or O blood type antigens or which are acid and/or bile tolerant, their use in probiotic compositions and food products, and methods for their selection. The invention also relates to the use of said bacteria and metabolites for the prevention and/or treatment of gastrointestinal disorders.
    Type: Application
    Filed: September 12, 2017
    Publication date: March 19, 2020
    Inventors: Heli Putaala, Sofia Forssten, Sampo Lahtinen, Arthur Ouwehand, Jaana Mättö, Harri Mäkivuokko, Janne Nikkilä
  • Lactic acid bacteria and for treating endotoxemia
    Patent number: 10543239
    Abstract: The invention relates to use of a bacterium selected from a lactic acid bacterium, a Bifidobacterium or a mixture of any thereof for treating metabolic endotoxemia, inhibiting bacterial translocation and regulating lipid absorption in a mammal.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: January 28, 2020
    Assignee: DuPont Nutrition Biosciences ApS
    Inventors: Remy Burcelin, Didier Carcano, Pierre Desreumaux, Sampo Lahtinen, Nina Rautonen, Heli Putaala, Kirsti Tiihonen, Rodolphe Barrangou
  • Bifidobacteria for treating cardiac conditions
    Patent number: 10471110
    Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction, dilated cardiomyopathy, inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis), and congestive heart failure.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: November 12, 2019
    Assignee: DuPont Nutrition Biosciences ApS
    Inventors: Lotta Stenman, Sampo Lahtinen, John Konhilas
  • BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS
    Publication number: 20190307815
    Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.
    Type: Application
    Filed: December 6, 2018
    Publication date: October 10, 2019
    Inventors: REMY BURCELIN, DIDIER CARCANO, SAMPO LAHTINEN
  • Method of Treatment
    Publication number: 20190269741
    Abstract: The present invention relates to a method of treating or prophlaxis of a respiratory tract illness in a subject comprising administering to said subject a composition comprising Bifidobacterium lactis BL04 and/or fermentation product of Bifidobacterium lactis BL04 and/or a cell lysate of Bifidobacterium lactis BL04.
    Type: Application
    Filed: January 2, 2019
    Publication date: September 5, 2019
    Inventors: David PYNE, Nicolas West, Allan Cripps, Sampo Lahtinen
  • BIFIDOBACTERIA FOR REDUCING FOOD, ENERGY AND/OR FAT INTAKE
    Publication number: 20190134113
    Abstract: This invention relates to the use of a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis strain 420 (B420) for use in reducing food, energy and/or fat intake.
    Type: Application
    Filed: April 6, 2017
    Publication date: May 9, 2019
    Inventors: Lotta Stenman, Sampo Lahtinen
  • BIFIDOBACTERIA FOR INCREASING LEAN BODY MASS
    Publication number: 20190105358
    Abstract: This invention relates to the use of a composition comprising a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis (strain) 420 (B420), and one or more prebiotics and/or fibres, for use in increasing lean body mass in a mammal.
    Type: Application
    Filed: April 6, 2017
    Publication date: April 11, 2019
    Inventors: Lotta Stenman, Sampo Lahtinen